GlassScriptPhysician profile
Danielle Thompson Harris
NPI 1043421159
$603.16
in general payments reported to CMS, 2019-2025
23 companies · $83.45 in 2025
The $83.45 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $78.88 · 2023: $76.84 · 2024: $181 · 2025: $83.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $72.89 | 2019-2020 | |
| Pfizer INC. | $57.00 | 2019-2024 | |
| Sage Therapeutics, LLC | $51.51 | 2024 | |
| Amag Pharmaceuticals, INC. | $34.35 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $30.98 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $29.90 | 2019-2020 | |
| Astellas Pharma US INC | $29.81 | 2020-2023 | Veozah |
| Exact Sciences Corporation | $29.60 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $26.83 | 2019-2023 | |
| Coopersurgical, INC. | $25.86 | 2019-2025 | Sos |
| Medtronic, INC. | $24.01 | 2023 | Ligasure |
| Mayne Pharma Commercial LLC | $19.87 | 2025 | |
| Neos Therapeutics, LP | $19.82 | 2019 | |
| Smith+Nephew, INC. | $19.16 | 2024 | Pico |
| Dexcom, INC. | $18.29 | 2025 | Dexcom G6 Transmitter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $15.95 | 2024 | |
| Exeltis, USA INC. | $15.86 | 2020 | |
| Hologic Sales and Service, LLC | $14.83 | 2024 | Fluent Fluid Management System |
| Organon LLC | $14.17 | 2024 | |
| Millicent US INC | $13.93 | 2019 | |
| Pharmacosmos Therapeutics INC. | $13.10 | 2024 | Monoferric |
| Daiichi Sankyo INC. | $13.08 | 2019 | |
| Merck Sharp & Dohme LLC | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.